insights_auto
Outlook: 78.1% bullish·3.1% bearish
Go to analysischevron_right
AMGN34:BVMF
Amgen Inc. BDR
91,89 R$
0,00%
(0,00) 1D
9 նոյ, 17:53:52 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN34...
Open
90,54 R$
High
91,89 R$
Low
90,54 R$
Mkt. cap
251,65 մլրդ
Avg. vol.
310,00
Volume
32,00
52-wk high
94,72 R$
52-wk low
47,76 R$
Shares outstanding
540,91 մլն
No. of employees
32 հզր
Open
90,54 R$
High
91,89 R$
Low
90,54 R$
Mkt. cap
251,65 մլրդ
Avg. vol.
310,00
Volume
32,00
52-wk high
94,72 R$
52-wk low
47,76 R$
Shares outstanding
540,91 մլն
No. of employees
32 հզր
News stories
From web sources and news partners
Investing.com Canada
·
7 ժամ առաջ
Form 4 Amgen Inc: Omar Ishrak (Director) For: 6 November By Investing.com
MarketWatch
·
11 ժամ առաջ
Amgen Inc. stock rises Monday, still underperforms market
Yahoo Finance UK
·
19 ժամ առաջ
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
24/7 Wall St.
·
1 օր առաջ
Amgen’s Dividend Has Grown 800% Since 2011. Here’s What It Pays Today
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc. BDR
CEORobert A. Bradway
Employees31,5 հզր
Founded1980
HeadquartersԹաուզենդ Օուքս, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websiteamgen.com